NCT00467935View on ClinicalTrials.gov

Scotoma Reduction in AMD Patients Treated With Ranibizumab

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Macular Degeneration
Interventions
DRUG

intravitreal injection Lucentis (ranibizumab)

intravitreal injection Lucentis (ranibizumab)

Trial Locations (1)

12159

Retina Research Center, Slingerlands

All Listed Sponsors
lead

Retina Research Foundation

OTHER

NCT00467935 - Scotoma Reduction in AMD Patients Treated With Ranibizumab | Biotech Hunter | Biotech Hunter